228
Views
32
CrossRef citations to date
0
Altmetric
Original

Quality of life in schizophrenic patients: Association with depressive symptoms

, PhD &
Pages 32-37 | Published online: 12 Jul 2009

References

  • Markou P. Depression in schizophrenia: A descriptive study. Aus NZ J Psychiatry 1996; 30: 354–7
  • Mechanic D, McAlpine D, Rosenfield S, Davis D. Effects of illness attribution and depression on the quality of life among persons with serious mental illness. Soc Sci Med 1994; 39: 155–64
  • Lehman AF, Burns BJ. Severe mental illness in the community. Quality of life and pharmacoeconomics in clinical trials2nd edition, B Spilker. Lippincott-Raven, New York 1996; 919–24
  • The WHOQOL Group. Development of the World Health Organisation WHOQOL-BREF quality of life assessment. Psychol Med 1998; 28: 551–8
  • Noerholm V, Bech P. The WHO quality of life (WHOQOL) questionnaire: Danish validity study. Nord J Psychiatry 2001; 55: 229–35
  • Noerholm V, Groenvold M, Watt T, Bjorner JB, Rasmussen N-A, Bech P. Quality of life in the Danish general population – Normative data and validity of WHOQOL-BREF using Rasch and item response theory models. Qual Life Res 2004; 13: 531–40
  • Olsen LR, Nørholm V, Rasmussen N-A, Watt T, Grønvold M, Bjørner J, et al. Major depression and psychological well-being in the general Danish population. Eur Psychiatry 2000; 15 Suppl 2: 388s
  • World Health Organisation. The ICD-10 classification of mental and behavioural disorders. Diagnostic criteria for research. World Health Organisation, Geneva 1993
  • Bech P, Larsen JK, Andersen J. The BPRS: Psychometric developments. Psychopharmacol Bull 1988; 24: 118–21
  • The WHOQOL Group. The world health organization quality of life assessment (WHOQOL): Development and general psychometric properties. Soc Sci Med 1998; 46: 1569–85
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition (DSM IV). Washington, DC: American Psychiatric Association; 1994.
  • Bech P, Rasmussen N-A, Olsen LR, Nørholm V, Abildgaard W. The sensitivity and specificity of the Major Depression Inventory using the present state examination as the index of diagnostic validity. Affect Disord 2001; 66: 159–60
  • Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P. The internal and external validity of the Major Depression Inventory in measuring severity of depressive states. Psychol Med 2003; 33: 351–6
  • Mokken RJ. A theory and procedure of scale analysis. Mouton, Paris 1971
  • Molenaar IW, Debets P, Sijtsma K, Hemker BT. User's manual MSP: A program for Mokken Scale Analysis for Polytomous Items, version 3.0. Groningen: iec ProGamma; 1994.
  • van der Heijden PG, van Buuren S, Fekkes M, Radder J, Verrips E. Unidimensionality and reliability under Mokken scaling of the Dutch language version of the SF-36. Qual Life Res 2003; 12: 189–98
  • Bech P. Rating scales for psychopathology, health status, and quality of life. Springer, Berlin 1993
  • Bech P, Olsen LR, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms. Int Meth Psych Res 2003; 12: 85–91
  • Schütze T, Noerholm V, Raabaek Olsen L, Hougaard H, Ekstroem M, Wagn P, et al. Reliability and validity of the Danish version of the Calgary Depression Scale for Schizophrenia. Nord J Psychiatry 2001; 55: 119–22
  • Voruganti L, Heslegrave R, Awad AG, Seeman MV. Quality of life measurement in schizophrenia: Reconciling the quest for subjectivity with the question of reliability. Psychol Med 1998; 28: 165–72
  • Awad AG. Quality of life of schizophrenic patients on medications and implications for new drug trials. Hosp Community Psychiatry 1992; 43: 262–5
  • Voruganti L, Awad AG. Neuroleptic dysphoria: Towards a new synthesis. Psychopharmacol 2004; 171: 121–32
  • Klysner R, Butler B, Vilamr T, Bech P. Empirical versus prospective pharmacokinetic dosing of perfenazine in schizophrenic and acute paranoid disorders. Preliminary findings. Nord Psykiatr Tidsskr 1986; 40: 473–7
  • Bobes J, Gonzales MP. Quality of life in schizophrenia. Quality of life in mental disorders, H Katschnig, H Freeman, N Sartorius. John Wiley & Sons, New York 1997; 165–78

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.